Heidy King-Jones, Chief Legal Officer and Corporate Secretary, on September 01, 2026, sold 28,399 shares in Spyre Therapeutics (SYRE) for $2,480,529. Following the Form 4 filing with the SEC, King-Jones has control over a total of 2,845 common shares of the company, with 2,845 shares held directly.
SEC Filing: